Items where authors include "Hussain, S.A."

Article

Jones, R.J. orcid.org/0000-0002-2904-6980, Crabb, S.J. orcid.org/0000-0003-3521-9064, Linch, M. et al. (7 more authors) (2024) Systemic anticancer therapy for urothelial carcinoma: UK oncologists’ perspective. British Journal of Cancer, 130 (6). pp. 897-907. ISSN 0007-0920

Jubber, I. orcid.org/0000-0002-4558-2521, Morhardt, D.R., Griffin, J. orcid.org/0000-0003-3969-7637 et al. (10 more authors) (2023) Analysis of the distal urinary tract in larval and adult zebrafish reveals homology to the human system. Disease Models & Mechanisms, 16 (7). dmm050110. ISSN 1754-8403

Catto, J.W.F. orcid.org/0000-0003-2787-8828, Mandrik, O. orcid.org/0000-0003-3755-3031, Quayle, L.A. et al. (12 more authors) (2023) Diagnosis, treatment and survival from bladder, upper urinary tract and urethral cancers: real-world findings from NHS England between 2013 and 2019. BJU International. ISSN 1464-4096

James, N.D., Liu, W., Pirrie, S. orcid.org/0000-0002-2894-2230 et al. (9 more authors) (2022) TUXEDO: a phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer. BJU International, 131 (1). pp. 63-72. ISSN 1464-4096

Conroy, S., Pang, K., Jubber, I. et al. (5 more authors) (2022) Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients. BJUI Compass. ISSN 2688-4526

Conroy, S., Hubbard, R., Noon, A.P. et al. (4 more authors) (2022) Case of the month from the University of Sheffield, UK : expediting definitive treatment in patients with invasive bladder cancer : an MRI-guided pathway. BJU International, 129 (6). pp. 691-694. ISSN 1464-4096

Hussain, S.A. orcid.org/0000-0003-1552-511X, Lester, J.F., Jackson, R. et al. (17 more authors) (2022) Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE) : a double-blind, randomised, phase 2 trial. The Lancet Oncology, 23 (5). pp. 650-658. ISSN 1470-2045

van der Heijden, MS, Powles, T, Petrylak, D et al. (22 more authors) (2022) Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial. Nature Communications, 13. 1878. ISSN 2041-1723

Williams, S.T., El Badri, S. and Hussain, S.A. orcid.org/0000-0003-1552-511X (2021) Urological cancer patients receiving treatment during COVID-19 : a single-centre perspective. British Journal of Cancer, 124 (9). pp. 1513-1515. ISSN 0007-0920

Ürün, Y., Hussain, S.A. orcid.org/0000-0003-1552-511X, Bakouny, Z. et al. (13 more authors) (2020) Survey of the impact of COVID-19 on oncologists’ decision making in cancer. Jco Global Oncology, 6. pp. 1248-1257. ISSN 2687-8941

Elmetwali, T., Salman, A., Wei, W. et al. (3 more authors) (2020) CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation. Scientific Reports, 10 (1). 342.

Hussain, S.A. orcid.org/0000-0003-1552-511X, Palmer, D.H., Syn, W.K. et al. (11 more authors) (2017) Gene expression profiling in bladder cancer identifies potential therapeutic targets. International Journal of Oncology, 50 (4). pp. 1147-1159. ISSN 1019-6439

Al-Jameel, W., Gou, X., Forootan, S.S. et al. (7 more authors) (2017) Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5. OncoTargets and Therapy, 8 (19). pp. 31041-31056. ISSN 1178-6930

Hussain, S.A. orcid.org/0000-0003-1552-511X, Ansari, J., Huddart, R. et al. (10 more authors) (2017) VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium: A retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through Free of Charge Programme for patients in the UK and Ireland. International Journal of Oncology, 50 (3). pp. 768-772. ISSN 1791-2423

Choudhury, A., West, C.M., Porta, N. et al. (7 more authors) (2017) The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004). British Journal of Cancer, 116 (5). pp. 649-657. ISSN 0007-0920

Al Fayi, M.S., Gou, X., Forootan, S.S. et al. (6 more authors) (2016) The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance. Oncotarget, 7 (50). pp. 82783-82797. ISSN 1949-2553

Andronis, L., Goranitis, I., Pirrie, S. et al. (19 more authors) (2016) Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747). BJU International. ISSN 1464-4096

Ansari, J., Hussain, S.A. orcid.org/0000-0003-1552-511X, Ansari, A. et al. (1 more author) (2013) Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma. Biologics: Targets and Therapy, 7. pp. 39-46. ISSN 1177-5475